(3R)-1-(2-amino-4-methyl-1,3-thiazol-5-yl)-3-[4-[1-[5-[(2,2-difluorocyclopropyl)methoxy]-2-pyridinyl]pyrrolidin-3-yl]oxyphenyl]butan-1-one;(1S)-1-[4-[1-[5-[(2,2-difluorocyclopropyl)methoxy]-2-pyridinyl]pyrrolidin-3-yl]oxyphenyl]ethanamine
C48H55F4N7O5S — CID 158850041
Data last refreshed: (MolForge compound catalog, from PubChem)
About (3R)-1-(2-amino-4-methyl-1,3-thiazol-5-yl)-3-[4-[1-[5-[(2,2-difluorocyclopropyl)methoxy]-2-pyridinyl]pyrrolidin-3-yl]oxyphenyl]butan-1-one;(1S)-1-[4-[1-[5-[(2,2-difluorocyclopropyl)methoxy]-2-pyridinyl]pyrrolidin-3-yl]oxyphenyl]ethanamine
(3R)-1-(2-amino-4-methyl-1,3-thiazol-5-yl)-3-[4-[1-[5-[(2,2-difluorocyclopropyl)methoxy]-2-pyridinyl]pyrrolidin-3-yl]oxyphenyl]butan-1-one;(1S)-1-[4-[1-[5-[(2,2-difluorocyclopropyl)methoxy]-2-pyridinyl]pyrrolidin-3-yl]oxyphenyl]ethanamine (PubChem CID 158850041) has the molecular formula C48H55F4N7O5S and a molecular weight of 918.07 g/mol. Its IUPAC name is (3R)-1-(2-amino-4-methyl-1,3-thiazol-5-yl)-3-[4-[1-[5-[(2,2-difluorocyclopropyl)methoxy]-2-pyridinyl]pyrrolidin-3-yl]oxyphenyl]butan-1-one;(1S)-1-[4-[1-[5-[(2,2-difluorocyclopropyl)methoxy]-2-pyridinyl]pyrrolidin-3-yl]oxyphenyl]ethanamine.
Molecular Properties
| Compound Name | (3R)-1-(2-amino-4-methyl-1,3-thiazol-5-yl)-3-[4-[1-[5-[(2,2-difluorocyclopropyl)methoxy]-2-pyridinyl]pyrrolidin-3-yl]oxyphenyl]butan-1-one;(1S)-1-[4-[1-[5-[(2,2-difluorocyclopropyl)methoxy]-2-pyridinyl]pyrrolidin-3-yl]oxyphenyl]ethanamine |
|---|---|
| PubChem CID | 158850041 |
| Molecular Formula | C48H55F4N7O5S |
| Molecular Weight | 918.07 g/mol |
| Exact Mass | 917.39 |
| IUPAC Name | (3R)-1-(2-amino-4-methyl-1,3-thiazol-5-yl)-3-[4-[1-[5-[(2,2-difluorocyclopropyl)methoxy]-2-pyridinyl]pyrrolidin-3-yl]oxyphenyl]butan-1-one;(1S)-1-[4-[1-[5-[(2,2-difluorocyclopropyl)methoxy]-2-pyridinyl]pyrrolidin-3-yl]oxyphenyl]ethanamine |
| SMILES | C[C@H](N)c1ccc(OC2CCN(c3ccc(OCC4CC4(F)F)cn3)C2)cc1.Cc1nc(N)sc1C(=O)C[C@@H](C)c1ccc(OC2CCN(c3ccc(OCC4CC4(F)F)cn3)C2)cc1 |
| InChI | InChI=1S/C27H30F2N4O3S.C21H25F2N3O2/c1-16(11-23(34)25-17(2)32-26(30)37-25)18-3-5-20(6-4-18)36-22-9-10-33(14-22)24-8-7-21(13-31-24)35-15-19-12-27(19,28)29;1-14(24)15-2-4-17(5-3-15)28-19-8-9-26(12-19)20-7-6-18(11-25-20)27-13-16-10-21(16,22)23/h3-8,13,16,19,22H,9-12,14-15H2,1-2H3,(H2,30,32);2-7,11,14,16,19H,8-10,12-13,24H2,1H3/t16-,19?,22?;14-,16?,19?/m10/s1 |
| InChIKey | IZIGXMUJBRNSON-QRCVCLOYSA-N |
| XLogP | 9.29 |
| TPSA | 151.18 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 13 |
| Rotatable Bonds | 17 |
| Heavy Atoms | 65 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 918.07 |
| LogP ≤ 5 | 9.29 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 13 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158850041 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.